Tareno Sustainable Health­care Fund: Oppor­tu­ni­ties in the Health­care Sector

Health­care is much more than just a defen­sive compo­nent of a portfolio. The Tareno Sustainable Health­care Fund invests globally in select, high-quality compa­nies that benefit from long-term growth drivers and contri­bute to more efficient health­care through innova­tive solutions.

Struc­tural Growth Drivers in the Health­care Sector

The Tareno Sustainable Health­care Fund is aimed at investors who seek to combine long-term growth oppor­tu­ni­ties with economic stabi­lity and who wish to benefit from the struc­tural megatrends in the health­care sector.

Health­care is a funda­mental compo­nent of modern society and is crucial for maintai­ning and impro­ving quality of life. Invest­ments in this sector are supported by strong struc­tural growth drivers, inclu­ding an aging popula­tion, the rising number of chronic diseases due to changing lifestyles, and incre­a­sing health­care spending, parti­cu­larly in emerging markets. At the same time, innova­tion and digita­lization are trans­forming the health­care sector and creating new growth oppor­tu­ni­ties.

However, these demogra­phic and societal megatrends are placing enormous pressure on the global health­care system and call for innova­tion. This is precisely where the fund comes in: The Tareno Sustainable Health­care Fund bridges the gap between growing demand and sustainable solutions. As an SFDR Article 9 fund, it pursues the clear sustainable goal of investing in compa­nies that provide concrete solutions to improve health and well-being, thereby helping to streng­then health­care systems.

Quality, Innova­tion, and Effici­ency

The fund achieves this objec­tive by selec­ting compa­nies with diffe­ren­tiated products and services that speci­fi­cally contri­bute to the impact themes of “Quality,” “Innova­tion,” and “Effici­ency” developed by the invest­ment manager. The focus is on solutions that increase effici­ency, reduce costs, and improve medical care.

The fund invests globally and across all health­care subsec­tors, such as medical techno­logy, pharmaceu­ti­cals, biotech­no­logy, health­care services, life sciences tools & services, and health­care techno­logy. The portfolio is constructed based on a purely bottom-up stock selec­tion process. The weightings of the subsec­tors and count­ries result from the respec­tive stock selec­tion. Invest­ments are made in compa­nies with strong balance sheets, a high return on equity, and diver­si­fied product portfo­lios. Prefe­rence is given to compa­nies that generate high cash flows and reinvest them in a sustainable and profi­table manner.

Health­care as a Diver­si­fi­ca­tion Strategy in a Portfolio

The fund offers investors the oppor­tu­nity to add attrac­tively valued, high-quality compa­nies with long-term growth poten­tial to their portfo­lios. Many compa­nies in the health­care sector are currently trading at attrac­tive valua­tions, offering intere­sting entry oppor­tu­ni­ties.

At the same time, health­care can serve as a defen­sive compo­nent in a portfolio. In a market environ­ment charac­te­rized by high valua­tions and a strong concen­tra­tion on techno­logy, semicon­duc­tors, and AI, the health­care sector can help diver­sify the portfolio and reduce cluster risks. In times of heigh­tened market volati­lity, defen­sive quality stocks can also benefit from portfolio reallo­ca­tions away from more cyclical sectors and those more heavily influenced by market expec­ta­tions.

A focused and sustainable invest­ment approach

The Tareno Sustainable Health­care Fund stands out thanks to its specia­lized team, which combines exten­sive invest­ment experi­ence, deep industry exper­tise, and scien­tific research. With a consi­stent high-convic­tion approach, the portfolio focuses on 30 to 50 selected compa­nies. Funda­mental analysis is comple­mented by a proprie­tary process that syste­ma­ti­cally integrates sustaina­bi­lity into company analysis and links ESG factors to long-term finan­cial value creation. We are convinced that compa­nies that operate sustain­ably are more successful in the long term.

2025-12-11-Tareno-Team-Health-Care2568-copy-1164x840

Fund Manage­ment of the Tareno Sustainable Health­care Fund

The three-person team is led by Dr. Maria Specogna. Together with Raphael Oesch, she serves as portfolio manager for the Tareno Sustainable Health­care Fund, while Flavio Mancino works as a research analyst. Each team member contri­butes specific exper­tise and helps ensure a compre­hen­sive analysis of compa­nies by covering their own equity universe.

LEARN MORE ABOUT THE TEAM AND THE HEALTH­CARE SECTOR

Dr. Maria Specogna has more than 25 years of experi­ence in the health­care sector, inclu­ding 20 years in sustainable investing. Previously, she worked at Vontobel Asset Manage­ment, Swiss Re, and Credit Suisse, among others. She studied bioche­mi­stry at the Univer­sity of Zurich and earned her Ph.D. there. She is also a Swiss Finan­cial Analyst. She has been part of the health­care team since 2016.

Raphael Oesch has over 16 years of experi­ence in the invest­ment sector, inclu­ding more than 12 years in the health­care sector. His areas of focus include medtech, managed care, health­care services, and health­care techno­logy. He previously worked as an equity analyst at BZ Bank. He holds an MSc in Banking & Finan­cial Manage­ment and is a CFA charter­holder. He has been a member of the health­care team since 2014.

Flavio Mancino has more than 12 years of experi­ence in asset manage­ment, inclu­ding seven years in the health­care sector. Previously, he worked at Vontobel Asset Manage­ment and LGT Bank, among other firms. He holds a bachelor’s degree in Banking & Finance from ZHAW and has passed all three CFA levels. He has been part of the health­care team since 2019.

Learn more about our exper­tise in the health­care sector

Discover the Sustainable Health­care Fund

Subscribe to the Health­care Newsletter

Disclaimer

This document has been prepared for marke­ting and infor­ma­tional purposes and does not consti­tute an offer or a solici­ta­tion to subscribe to, buy, or sell shares of this invest­ment fund. It does not consti­tute invest­ment advice. Only the current fund documents (in parti­cular, the prospectus and KID) are exclu­si­vely autho­ri­ta­tive. Past perfor­mance is not a reliable indicator of future results.

Images: Marijke Vosmeer, Luzia Hunziker, Jürg Kaufmann, Istock, Unsplash / Graphics: Tareno AG / Bloom­berg